Heart Failure Research

Heart failure, also known as congestive heart failure or CHF, is an inability of the heart to pump sufficient blood around the body.Heart failure typically occurs secondary to an existing pathology that alters cardiac function. Examples of syndromes that can precede heart failure include myocardial infarction, arrhythmia or infection. These can also cause dilated cardiomyopathy, a condition which accounts for approximately one third of all cases of heart failure. The pathogenesis of heart failure is cyclical and progressive; endogenous mechanisms, which are activated during heart failure in an attempt to counteract the symptoms, actually worsen cardiac function. Cardiac dysfunction, either systolic or diastolic, triggers a decrease in stroke volume and a resultant increase in cardiac output. In healthy individuals the body responds to decreases in cardiac output by initiating the renin-angiotensin-aldosterone system (RAAS) to promote fluid retention, and also by activating the sympathetic nervous system to cause peripheral vasoconstriction. Under normal circumstances this counteracts the imbalance in stroke volume, restoring cardiac output to normal levels. In patients with heart failure the increase in blood volume, together with the heightened peripheral resistance and elevated levels of circulating catecholamines, causes an increased load on the already weakened ventricles with each contraction, and the stroke volume does not return to normal levels. Repeated cycles of this process further weaken the ventricle walls, prompting ventricular hypertrophy and a decreased force of contraction.

Heart Failure Research Products Targets

Products for Heart Failure Research - Page 3

  1. Cat.No. Product Name Information/Activity
  2. BCC6883 AH 11110 hydrochloride 179388-65-9 AH 11110 hydrochloride chemical structure
  3. BCC6705 3-MPPI 133399-65-2 3-MPPI chemical structure
  4. BCC1417 B-HT 920 Talipexole dihydrochloride (B-HT 920 dihydrochloride) is a dopamine D2 receptor agonist, α2-adrenoceptor agonist and 5-HT3 receptor antagonist, which displays antiParkinsonian activity. B-HT 920 chemical structure
  5. BCC7474 B-HT 933 dihydrochloride 36067-72-8 B-HT 933 dihydrochloride chemical structure
  6. BCC4325 Clonidine HCl Clonidine hydrochloride is an agonist of α2-adrenoceptor and potent antihypertensive agent. Clonidine HCl chemical structure
  7. BCC4347 Dexmedetomidine HCl Dexmedetomidine Hydrochloride is an agonist of adrenergic alpha-2 receptor, which is used in veterinary medicine for its analgesic and sedative properties. Dexmedetomidine HCl chemical structure
  8. BCC4327 Guanabenz Acetate Guanabenz (Acetate) (BR-750) is an alpha-2 selective adrenergic agonist used as an antihypertensive agent. Guanabenz Acetate chemical structure
  9. BCC1609 Guanfacine hydrochloride Guanfacine hydrochloride, an anti-hypertensive agent, is a selective α2A-adrenoceptor agonist with Kd of 31 nM and displays 60-fold selectivity over α2B-adrenoceptors. Guanfacine hydrochloride chemical structure
  10. BCC4351 Medetomidine HCl Medetomidine hydrochloride is an agonist of adrenergic alpha-2 receptor, which is used in veterinary medicine for its analgesic and sedative properties. Medetomidine HCl chemical structure
  11. BCC5163 Moxonidine hydrochloride Moxonidine Hydrochloride is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent. Moxonidine hydrochloride chemical structure

Items 21 to 30 of 148 total